Our data underscores the necessity and significance of further research on the role of IgA glycosylation in the modulation of pathogen-specific immune responses with the aim of designing effective targeted intervention strategies that focus on antibody glycosylation in COVID-19 and other infection diseases. The gene discussed is CD79A; the disease is COVID-19.